BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1668432)

  • 1. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
    Karimov ShI; Kim VF; Iunusov IR
    Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complex treatment of complications of liver cirrhosis].
    Borisov AE; Levin LA; Borisova NA; Verkhovskiĭ VS; Mosiagin VB; Faĭnzi'lberg SI
    Vestn Khir Im I I Grek; 1989 Jun; 142(6):21-5. PubMed ID: 2815466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular embolization of the hepatolienal vessels in the treatment of portal hypertension.
    Karimov ShI; Borovskiĭ SP; Rakhmanov SU; Atakhanov DA
    Angiol Sosud Khir; 2003; 9(2):40-6. PubMed ID: 12811373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Splenectomy in patients with liver cirrhosis complicated by portal hypertension].
    Patsiora MD; Kniazeva GD; Ershov IuA; Morozov VA; Chumachenko PV
    Khirurgiia (Mosk); 1983 Jul; (7):60-3. PubMed ID: 6620913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term results of the embolization of the hepatic and splenic arteries in liver cirrhosis].
    Granov AM; Ryzhkov VK; Tarazov PG
    Khirurgiia (Mosk); 1991 Nov; (11):84-8. PubMed ID: 1779561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The results of endovascular embolization of the gastric veins in patients with portal hypertension complicated by esophagogastric hemorrhage].
    Prokubovskiĭ VI; Cherkasov VA
    Vestn Khir Im I I Grek; 1993; 151(7-12):16-9. PubMed ID: 7975008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of splenic artery embolization in treating complicated liver cirrhosis].
    Kalita NIa; Bulanov KI; Nikishin LF; Kondratiuk VA; Egorova ON
    Klin Khir; 1995; (9-10):5-9. PubMed ID: 8697221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laparoscopic splenectomy and pericardial devascularization for treatment of portal hypertension due to liver cirrhosis].
    Hong DF; Zheng XY; Peng SY; Gao M; Wu JG; Cao Q
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):820-2. PubMed ID: 17565864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the surgical procedure in treating subcompensated portal hypertension in liver cirrhosis].
    Nazyrov FG; Vakhidov AV; Deviatov AV; Akilov KhA; Mansurov AA
    Vestn Khir Im I I Grek; 1992; 149(11-12):318-22. PubMed ID: 8594788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
    Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV
    Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial splenic embolization as treatment for portal hypertension].
    Iijima T; Kojima T; Koitabashi H; Shiojima M; Osumi M; Nakano G; Nagamachi Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Nov; 47(11):1405-12. PubMed ID: 3447091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.